Variant report
Variant | esv3436842 |
---|---|
Chromosome Location | chr20:23470252-23471750 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:8)
- CpG islands (count:367)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:8 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | CEBPB | chr20:23471614-23471730 | HepG2 | liver: | n/a | n/a |
2 | MYC | chr20:23470476-23470527 | MCF-7 | breast: | n/a | n/a |
3 | POLR2A | chr20:23471706-23471726 | MCF-7 | breast: | n/a | n/a |
4 | POLR2A | chr20:23470417-23470546 | MCF-7 | breast: | n/a | n/a |
5 | USF1 | chr20:23470393-23470547 | GM12878 | blood: | n/a | chr20:23470456-23470467 chr20:23470451-23470472 |
6 | USF1 | chr20:23470369-23470575 | GM12878 | blood: | n/a | chr20:23470456-23470467 chr20:23470451-23470472 |
7 | USF1 | chr20:23470344-23470564 | HepG2 | liver: | n/a | chr20:23470456-23470467 chr20:23470451-23470472 |
8 | USF1 | chr20:23470336-23470554 | SK-N-SH_RA | brain: | n/a | chr20:23470456-23470467 chr20:23470451-23470472 |
No. | Chromosome Location | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr20:23471737-23471787 | NH-A | brain: | n/a |
2 | chr20:23471737-23471787 | NH-A | brain: | n/a |
3 | chr20:23471711-23471761 | HRCEpiC | kidney: | n/a |
4 | chr20:23471627-23471677 | T-47D | breast: | n/a |
5 | chr20:23471711-23471761 | HCPEpiC | choroid plexus: | n/a |
6 | chr20:23471737-23471787 | BJ | skin: | n/a |
7 | chr20:23470461-23470511 | HCT-116 | colon: | n/a |
8 | chr20:23470274-23470324 | BJ | skin: | n/a |
9 | chr20:23471627-23471677 | GM06990 | blood: | n/a |
10 | chr20:23471627-23471677 | K562 | blood: | n/a |
11 | chr20:23470274-23470324 | MCF10A-Er-Src | breast: | n/a |
12 | chr20:23471737-23471787 | H1-hESC | embryonic stem cell: | embryo |
13 | chr20:23470274-23470324 | AG04450 | lung: | fetal |
14 | chr20:23471737-23471787 | HMEC | breast: | n/a |
15 | chr20:23470274-23470324 | A549 | lung: | n/a |
16 | chr20:23470274-23470324 | BE2_C | brain: | n/a |
17 | chr20:23470274-23470324 | AoSMC | blood vessel: | n/a |
18 | chr20:23471693-23471743 | HPAEpiC | pulmonary alveolar: | n/a |
19 | chr20:23471737-23471787 | AoSMC | blood vessel: | n/a |
20 | chr20:23471711-23471761 | AG10803 | skin: | n/a |
21 | chr20:23470274-23470324 | HPAEpiC | pulmonary alveolar: | n/a |
22 | chr20:23471711-23471761 | HCF | heart: | n/a |
23 | chr20:23471693-23471743 | PFSK-1 | brain: | n/a |
24 | chr20:23471627-23471677 | NHBE | bronchial: | n/a |
25 | chr20:23470461-23470511 | BJ | skin: | n/a |
26 | chr20:23471737-23471787 | BE2_C | brain: | n/a |
27 | chr20:23471711-23471761 | HMEC | breast: | n/a |
28 | chr20:23471627-23471677 | HCM | heart: | n/a |
29 | chr20:23470461-23470511 | GM19239 | blood: | n/a |
30 | chr20:23470274-23470324 | K562 | blood: | n/a |
31 | chr20:23470274-23470324 | PANC-1 | pancreas: | n/a |
32 | chr20:23470274-23470324 | Hepatocyte | liver: | n/a |
33 | chr20:23471693-23471743 | HUVEC | blood vessel: | n/a |
34 | chr20:23471711-23471761 | U87 | brain: | n/a |
35 | chr20:23470274-23470324 | T-47D | breast: | n/a |
36 | chr20:23471627-23471677 | LNCaP | prostate: | n/a |
37 | chr20:23471627-23471677 | HEK293 | kidney: | embryo |
38 | chr20:23470274-23470324 | GM12891 | blood: | n/a |
39 | chr20:23470274-23470324 | HRPEpiC | eye: | n/a |
40 | chr20:23470274-23470324 | SK-N-MC | brain: | n/a |
41 | chr20:23470461-23470511 | H1-hESC | embryonic stem cell: | embryo |
42 | chr20:23471711-23471761 | MCF10A-Er-Src | breast: | n/a |
43 | chr20:23471693-23471743 | HL-60 | blood: | n/a |
44 | chr20:23470461-23470511 | GM12892 | blood: | n/a |
45 | chr20:23471627-23471677 | HL-60 | blood: | n/a |
46 | chr20:23471737-23471787 | SAEC | small airway: | n/a |
47 | chr20:23471627-23471677 | HUVEC | blood vessel: | n/a |
48 | chr20:23470274-23470324 | AG09319 | gingival: | n/a |
49 | chr20:23471737-23471787 | SK-N-SH_RA | brain: | n/a |
50 | chr20:23471627-23471677 | U87 | brain: | n/a |
No data |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
CST8 | TF binding region |
CST8 | CpG island |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs538470840 | chr20:23470326-23470327 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs141666829 | chr20:23470337-23470338 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
3 | rs147081901 | chr20:23470410-23470411 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
4 | rs117058259 | chr20:23470411-23470412 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
5 | rs566231280 | chr20:23470414-23470415 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
6 | rs11700120 | chr20:23470419-23470420 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
7 | rs147730735 | chr20:23470434-23470435 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
8 | rs554597714 | chr20:23470441-23470442 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
9 | rs574396888 | chr20:23470560-23470561 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
10 | rs540876295 | chr20:23470578-23470579 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs181498345 | chr20:23470585-23470586 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs57693501 | chr20:23470643-23470644 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs139883004 | chr20:23470644-23470645 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs397805017 | chr20:23470653-23470654 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs141105599 | chr20:23470657-23470658 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs185888446 | chr20:23470676-23470677 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs189613711 | chr20:23470677-23470678 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs3991604 | chr20:23470719-23470720 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs186071093 | chr20:23470720-23470721 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs3991605 | chr20:23470722-23470723 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs367617675 | chr20:23470733-23470734 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs3991606 | chr20:23470744-23470745 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs548321625 | chr20:23470745-23470746 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs3991607 | chr20:23470746-23470747 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs3991608 | chr20:23470747-23470748 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs199947573 | chr20:23470751-23470752 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs3991609 | chr20:23470758-23470759 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs111053016 | chr20:23470768-23470769 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs2038387 | chr20:23470772-23470773 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs3067688 | chr20:23470774-23470775 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs570495882 | chr20:23470782-23470783 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs3991595 | chr20:23470783-23470784 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs546838274 | chr20:23470784-23470785 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs566675321 | chr20:23470795-23470796 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs538961936 | chr20:23470796-23470797 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs3991596 | chr20:23470799-23470800 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs3991597 | chr20:23470800-23470801 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs34299020 | chr20:23470807-23470808 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs71183343 | chr20:23470808-23470809 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs372685345 | chr20:23470809-23470810 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs13044324 | chr20:23470819-23470820 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs3991598 | chr20:23470820-23470821 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs3067700 | chr20:23470832-23470833 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs552385057 | chr20:23470833-23470834 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs3991599 | chr20:23470836-23470837 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs556265345 | chr20:23470837-23470838 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs568149302 | chr20:23470845-23470846 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs375828771 | chr20:23470846-23470847 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs368465403 | chr20:23470847-23470848 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs371864473 | chr20:23470848-23470849 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Wilms tumour | 21544195 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Breast cancer | 16272173 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Oral cancer | 19627613 | CNVD |
colon cancer | 17210682 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Cancer | 16751803 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Central neurocytomas | 17123091 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Gastric cancer | 17908304 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Colorectal cancer | 21645411 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Autism | 22495311 | CNVD |
Renal cell carcinoma | 18765545 | CNVD |
Alagille syndrome | 17576883 | CNVD |
Anaplastic large cell lymphoma | 18179710 | CNVD |
Prostate cancer | 18632612 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Cancer | 21183584 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
Pancreatic endocrine tumor | 17639061 | CNVD |
Breast cancer | 16608533 | CNVD |
Bladder cancer | 21909424 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Breast cancer | 17133270 | CNVD |
Thrombophilia | 17576883 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Mental retardation | 21062444 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Barrett''s adenocarcinoma | 18663352 | CNVD |
Chordoma | 18071362 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
small cell lung cancer | 17426248 | CNVD |
Breast cancer | 21364760 | CNVD |
Bipolar disorder | 19114987 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr20:23465800-23471000 | Weak transcription | H9 Cell Line | embryonic stem cell |
2 | chr20:23469400-23470600 | Enhancers | Primary B cells from cord blood | blood |
3 | chr20:23469600-23470600 | Enhancers | Primary B cells from peripheral blood | blood |
4 | chr20:23469600-23470600 | Enhancers | Fetal Muscle Leg | muscle |
5 | chr20:23469600-23473200 | Weak transcription | Gastric | stomach |
6 | chr20:23471400-23471600 | Enhancers | HepG2 | liver |
7 | chr20:23471600-23471800 | Enhancers | hESC Derived CD56+ Ectoderm Cultured Cells | ES cell derived |
8 | chr20:23471600-23472200 | Enhancers | K562 | blood |
9 | chr20:23471600-23472400 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
10 | chr20:23471600-23473400 | Bivalent Enhancer | HepG2 | liver |